Riskpilot← Back to searchSign inGet full accessÅSEN APOTEK AS
ASActiveOrg 920933963Ove Gjeddes Vei 110, 3610 KongsbergRetail sale of pharmaceutical products · NACE 4773Est. 20180 employees
Revenue 2022
NOK 12,6M
+12% vs 2021
EBITDA margin
4.8%
+9% vs 2021
Equity ratio
22.0%
Financial strength
Net profit 2022
NOK 408K
+20% vs 2021
| Revenue | NOK 12,6M | +12% |
| EBITDA | NOK 598K | +9% |
| Net profit | NOK 408K | +20% |
| Total assets | NOK 2,6M | +6% |
| Equity | NOK 570K | +252% |
| Employees | 0 | — |
Legal name
ÅSEN APOTEK AS
Org number
920933963
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
8. juni 2018
Share capital
NOK 700 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Eie og drive apotek og alt hva hermed står i forbindelse.
Address
Ove Gjeddes Vei 110, 3610 Kongsberg
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 1 913 | 7 155 | 9 346 | 11 245 | 12 562 |
| Staff expenses | −727 | −2 140 | −2 251 | −2 512 | −2 660 |
| EBITDA | −273 | −324 | 248 | 548 | 598 |
| Depreciation & amort. | −56 | −175 | −177 | −177 | −177 |
| EBIT | −329 | −499 | 71 | 371 | 421 |
| Net financials | −18 | −59 | −49 | −31 | −13 |
| Profit before tax | −347 | −558 | 22 | 340 | 408 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −347 | −558 | 22 | 340 | 408 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | 2 285 | 2 192 | 2 123 | 2 444 | 2 594 |
| Equity | −42 | −200 | −178 | 162 | 570 |
| Long-term debt | 1 127 | 906 | 679 | 445 | 207 |
| Short-term debt | 1 199 | 1 486 | 1 621 | 1 837 | 1 816 |
| Total debt | 2 327 | 2 392 | 2 301 | 2 282 | 2 024 |
EBITDA margin
4.8%
This company
15.8%
Market median
-70% vs market
20182022
Equity ratio
22.0%
This company
38.2%
Market median
-42% vs market
20182022
Return on equity
71.6%
This company
18.4%
Market median
+289% vs market
20182022
Net profit margin
3.3%
This company
8.1%
Market median
-59% vs market
20182022
Asset turnover
4.84×
This company
1.12×
Market median
+332% vs market
20182022
Debt / equity
3.55×
This company
0.62×
Market median
-473% vs market
20182022
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-05-10 – 2018-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
NA Chief Executive Officer | Chief Executive Officer | 2018 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2023 | |
| Chairman | 2023 | |
| Former (3) | ||
| Chairman | 2018 – 2023 | |
| Board of Directors | 2018 – 2023 | |
| Board of Directors | 2018 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 | |
| Company | 25% | 25% | 2022 | |
| Company | 25% | 25% | 2022 | |
| Company | 25% | 25% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Mckesson Norway Holding As
ÅSEN APOTEK AS Board members of ÅSEN APOTEK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nora Albakaa | Chief Executive Officer | 0 companies |
| Vegard Hoff | Board of Directors | 0 companies |
| Morten Frogner | Chairman | 0 companies |
| Michael Roland Ecker | Chairman | 0 companies |
| Jan Arne Frogner | Board of Directors | 0 companies |
| Einar Mathias Teigen Rasch-Halvorsen | Board of Directors | 0 companies |